Company: BBVXF
Filing Date: 2025-02-21
Form Type: 20-F
Source: 0000842180-25-000010
Chunk: 144

Company: BANCO BILBAO VIZCAYA ARGENTARIA, S.A.
Filing Date: 2025-02-21
Form: 20-F
Item: Item 5
Chunk 144
---
 breakdown of impairment or reversal of impairment on financial assets not measured at fair value through profit or loss or net gains by modification for the years ended December 31, 2024 and 2023:

                                                                                                                                                          Year ended December 31,               
2024                                                                                                                                                                         2023         Change
Impairment or reversal of impairment on:                                                                                                                   (In Millions of Euros)         (In %)
Financial assets at fair value through other comprehensive income                                                                                            58                42           38.2
Financial assets at amortized cost                                                                                                                        5,687             4,386           29.7
Impairment or reversal of impairment on financial assets not measured at fair value through profit or loss or net gains by modification                   5,745             4,428           29.7
Impairment or reversal of impairment on non-financial assets
Impairment or reversal of impairment on non-financial assets for the year ended December 31, 2024 amounted to €1 million of income, compared with the €54 million expense recorded for the year ended December 31, 2023.
Gains (losses) on derecognition of non-financial assets and subsidiaries, net and Impairment or reversal of impairment of investments in joint ventures and associates
Gains on derecognition of non-financial assets and subsidiaries, net and Impairment or reversal of impairment of investments in joint ventures and associates for the year ended December 31, 2024 amounted to €77 million, compared with the €19 million gain recorded for the year ended December 31, 2023, mainly due to the reversal impairment of certain investments in joint ventures and associates. 
Gains (losses) from non-current assets and disposal groups classified as held for sale not qualifying as discontinued operations
Losses from non-current assets and disposal groups classified as held for sale not qualifying as discontinued operations for the year ended December 31, 2024 amounted to €17 million, compared with the €22 million gains recorded for the year ended December 31, 2023. 
Operating profit / (loss) before tax
As a result of the foregoing, operating profit before tax for the year ended December 31, 2024 amounted to €15,405 million, a 24.0% increase compared with the €12,419 million operating profit before tax recorded for the year ended December 31, 2023.
Tax expense or income related to profit or loss from continuing operations